Search research articles
Contact Us
Filters
Showing results (301-310 of 330) with videos related to
Page
of 33
Sort By:
British Journal of Haematology
|
October 10, 2025
Incremental immunogenicity of multiple doses of SARS-CoV-2 vaccination in patients with haematological malignancies
Abi Vijenthira, Sita Bhella, Katrina Hueniken, et al.
NEJM Evidence
|
June 19, 2025
An Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma
Angie Mae Rodday, Andrew M Evens, Matthew J Maurer, et al.
Communications Biology
|
July 30, 2021
Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action
Rachel L Palte, Veronica Juan, Yacob Gomez-Llorente, et al.
Communications Biology
|
November 16, 2021
Author Correction: Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action
Rachel L Palte, Veronica Juan, Yacob Gomez-Llorente, et al.
Leukemia
|
October 7, 2018
Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study
Roch Houot, Guillaume Cartron, Fontanet Bijou, et al.
Frontiers in Immunology
|
February 5, 2025
Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections
Dana Unninayar, Emilia L Falcone, Hugo Chapdelaine, et al.
Transplantation and Cellular Therapy
|
November 10, 2025
Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy
C Arianne Buchan, Gerard Agbayani, Katrina Hueniken, et al.
American Journal of Ophthalmology
|
May 22, 2017
Reply
Audrey de Parisot, Yvan Jamilloux, Laurent Kodjikian, et al.
American Journal of Ophthalmology
|
April 4, 2017
Randomized Controlled Trial Evaluating a Standardized Strategy for Uveitis Etiologic Diagnosis (ULISSE)
Audrey de Parisot, Laurent Kodjikian, Marie-Hélène Errera, et al.
Hemasphere
|
January 14, 2022
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma
Roch Houot, Viola Poeschel, Bettina Altmann, et al.
Page
of 33
Search research articles
Search
Showing results (301-310 of 330) with videos related to
Sort By:
Page
of 33
British Journal of Haematology
|
October 10, 2025
Incremental immunogenicity of multiple doses of SARS-CoV-2 vaccination in patients with haematological malignancies
Abi Vijenthira, Sita Bhella, Katrina Hueniken, et al.
NEJM Evidence
|
June 19, 2025
An Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma
Angie Mae Rodday, Andrew M Evens, Matthew J Maurer, et al.
Communications Biology
|
July 30, 2021
Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action
Rachel L Palte, Veronica Juan, Yacob Gomez-Llorente, et al.
Communications Biology
|
November 16, 2021
Author Correction: Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action
Rachel L Palte, Veronica Juan, Yacob Gomez-Llorente, et al.
Leukemia
|
October 7, 2018
Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study
Roch Houot, Guillaume Cartron, Fontanet Bijou, et al.
Frontiers in Immunology
|
February 5, 2025
Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections
Dana Unninayar, Emilia L Falcone, Hugo Chapdelaine, et al.
Transplantation and Cellular Therapy
|
November 10, 2025
Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy
C Arianne Buchan, Gerard Agbayani, Katrina Hueniken, et al.
American Journal of Ophthalmology
|
May 22, 2017
Reply
Audrey de Parisot, Yvan Jamilloux, Laurent Kodjikian, et al.
American Journal of Ophthalmology
|
April 4, 2017
Randomized Controlled Trial Evaluating a Standardized Strategy for Uveitis Etiologic Diagnosis (ULISSE)
Audrey de Parisot, Laurent Kodjikian, Marie-Hélène Errera, et al.
Hemasphere
|
January 14, 2022
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma
Roch Houot, Viola Poeschel, Bettina Altmann, et al.
Page
of 33